Amedisys (AMED) Tops Q4 EPS by 18c; Issues FY23 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
Amedisys Reports Fourth Quarter and Year-End 2022 Financial Results, Issues 2023 Guidance, Announces Sale of Its Personal Care Line of Business and Signs Innovative Palliative Care at Home Partnership
February 15, 2023 4:10 PM ESTBATON ROUGE, La., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2022.
Three-Month Periods Ended December 31, 2022 and 2021
Net service revenue increased $2.7 million to $562.0 million compared to $559.3 million in 2021.Net income attributable to Amedisys, Inc. of $31.7 million compared to $34.0 million in 2021.Net income attributable to Amedisys, Inc. per diluted share of $0.97 compared to $1.04 in 2021.... More